Alzheimer’s Drug Discovery Foundation

The ADDF shares the BIRAX initiative’s commitment to innovation and its collaborative approach,” says Howard Fillit, MD, Founding Executive Director and Chief Science Officer of the ADDF. “We are enthusiastic about joining the partnership and working together to drive new therapies for Alzheimer’s disease.” 

Founded in 1998 by co-chairmen Leonard A. and Ronald S. Lauder, the Alzheimer’s Drug Discovery Foundation (ADDF) is dedicated to rapidly accelerating the discovery of drugs to prevent, treat and cure Alzheimer's disease. ADDF is the only public charity solely dedicated to the development of drugs for Alzheimer’s, employing a venture philanthropy model to fund research in academia and the biotech industry. Through the support of its donors, the ADDF has awarded $80 million to fund nearly 500 Alzheimer’s drug discovery programs and clinical trials in 18 countries. To learn more, visit: